TY - JOUR
T1 - Effect of N-acetylcysteine on cycling performance after intensified training
AU - Slattery, Katie May
AU - Dascombe, Ben
AU - Wallace, Lee Kenneth
AU - Bentley, David J.
AU - Coutts, Aaron James
PY - 2014
Y1 - 2014
N2 - Purpose: This investigation examined the ergogenic effect of short-term oral N-acetylcysteine (NAC) supplementation and the associated changes in redox balance and inflammation during intense training. Methods: A double-blind randomized placebo-controlled crossover design was used to assess 9 d of oral NAC supplementation (1200 mg.d(-1)) in 10 well-trained triathletes. For each supplement trial (NAC and placebo), baseline venous blood and urine samples were taken, and a presupplementation cycle ergometer race simulation was performed. After the loading period, further samples were collected preexercise, postexercise, and 2 and 24 h after the postsupplementation cycle ergometer race simulation. Changes in total antioxidant capacity, ferric reducing ability of plasma, reduced glutathione, oxidized glutathione, thiobarbituric acid-reactive substances, interleukin 6, xanthine oxidase, hypoxanthine, monocyte chemotactic protein 1, nuclear factor kappa B, and urinary 15-isoprostane F-2t concentration were assessed. The experimental procedure was repeated with the remaining supplement after a 3-wk washout. Eight participants completed both supplementation trials. Results: NAC improved sprint performance during the cycle ergometer race simulation (P < 0.001, eta(2)(p) = 0.03). Supplementation with NAC also augmented postexercise plasma total antioxidant capacity (P = 0.005, eta(2)(p) = 0.19), reduced exercise-induced oxidative damage (plasma thiobarbituric acid-reactive substances, P = 0.002, eta(2)(p) = 0.22; urinary 15-isoprostane F2t concentration, P = 0.010, eta(2)(p) = 0.431), attenuated inflammation (plasma interleukin 6, P = 0.002, eta(2)(p) = 0.22; monocyte chemotactic protein 1, P = 0.012, eta(2)(p) = 0.17), and increased postexercise nuclear factor kappa B activity (P < 0.001, eta(2)(p) = 0.21). Conclusion: Oral NAC supplementation improved cycling performance via an improved redox balance and promoted adaptive processes in well-trained athletes undergoing strenuous physical training.
AB - Purpose: This investigation examined the ergogenic effect of short-term oral N-acetylcysteine (NAC) supplementation and the associated changes in redox balance and inflammation during intense training. Methods: A double-blind randomized placebo-controlled crossover design was used to assess 9 d of oral NAC supplementation (1200 mg.d(-1)) in 10 well-trained triathletes. For each supplement trial (NAC and placebo), baseline venous blood and urine samples were taken, and a presupplementation cycle ergometer race simulation was performed. After the loading period, further samples were collected preexercise, postexercise, and 2 and 24 h after the postsupplementation cycle ergometer race simulation. Changes in total antioxidant capacity, ferric reducing ability of plasma, reduced glutathione, oxidized glutathione, thiobarbituric acid-reactive substances, interleukin 6, xanthine oxidase, hypoxanthine, monocyte chemotactic protein 1, nuclear factor kappa B, and urinary 15-isoprostane F-2t concentration were assessed. The experimental procedure was repeated with the remaining supplement after a 3-wk washout. Eight participants completed both supplementation trials. Results: NAC improved sprint performance during the cycle ergometer race simulation (P < 0.001, eta(2)(p) = 0.03). Supplementation with NAC also augmented postexercise plasma total antioxidant capacity (P = 0.005, eta(2)(p) = 0.19), reduced exercise-induced oxidative damage (plasma thiobarbituric acid-reactive substances, P = 0.002, eta(2)(p) = 0.22; urinary 15-isoprostane F2t concentration, P = 0.010, eta(2)(p) = 0.431), attenuated inflammation (plasma interleukin 6, P = 0.002, eta(2)(p) = 0.22; monocyte chemotactic protein 1, P = 0.012, eta(2)(p) = 0.17), and increased postexercise nuclear factor kappa B activity (P < 0.001, eta(2)(p) = 0.21). Conclusion: Oral NAC supplementation improved cycling performance via an improved redox balance and promoted adaptive processes in well-trained athletes undergoing strenuous physical training.
UR - https://hdl.handle.net/1959.7/uws:71604
U2 - 10.1249/MSS.0000000000000222
DO - 10.1249/MSS.0000000000000222
M3 - Article
SN - 0195-9131
VL - 46
SP - 1114
EP - 1123
JO - Medicine and Science in Sports and Exercise
JF - Medicine and Science in Sports and Exercise
IS - 6
ER -